BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6323189)

  • 1. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G; Valeriote F
    Cancer Chemother Pharmacol; 1986; 18(2):101-4. PubMed ID: 3791555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL; Carter WH; Campbell ED
    Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M; Miwa M; Ishitsuka H; Nitta K
    Cancer Chemother Pharmacol; 1987; 19(1):61-4. PubMed ID: 3028664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E; Szmigielska A; Robak T
    Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
    Ganu UK; Khandalekar DD; Gokhale SV
    Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphate.
    Iigo M; Hoshi A
    J Pharmacobiodyn; 1984 Jan; 7(1):67-9. PubMed ID: 6327964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
    Machida S; Ito Y; Hoshino A
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A; Ciesielska E; Szmigiero L; Robak T
    Eur J Haematol; 2002 Jun; 68(6):370-5. PubMed ID: 12225395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Robak T; Szmigielska A
    Neoplasma; 2000; 47(3):168-71. PubMed ID: 11043840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
    Palmeri S; Trave F; Russello O; Rustum YM
    Sel Cancer Ther; 1989; 5(4):169-77. PubMed ID: 2623382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
    Catsoulacos P; Camoutsis C; Wampler GL
    Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.